Chamming's Foucauld, Kao Ellen, Aldis Ann, Ferré Romuald, Omeroglu Atilla, Reinhold Caroline, Mesurolle Benoit
1 Radiology Department, McGill University Health Center, Montréal, QC, Canada.
2 Pathology Department, McGill University Health Center, Montréal, QC, Canada.
Br J Radiol. 2017 May;90(1073):20170128. doi: 10.1259/bjr.20170128. Epub 2017 Apr 3.
To review the imaging features of invasive lobular carcinoma (ILC) seen on digital breast tomosynthesis (DBT) in comparison with invasive ductal carcinoma (IDC), and to evaluate whether DBT could improve conspicuity and tumour size assessment of ILC in comparison with digital mammography (DM).
Institutional review board with waiver of informed consent was obtained for this retrospective study. Patients with ILC or IDC who underwent DBT and DM at the time of diagnosis were included. DM and DBT images were reviewed in consensus by two breast radiologists in order to assess imaging features, conspicuity and maximum tumour diameter of ILC and IDC. Pathology on the surgical specimen was considered the standard of reference for assessment of tumour size.
43 patients (20 patients with ILC and 23 patients with IDC) were included. On DBT, compared with IDC, ILC presented less frequently as masses (40% vs 78%) (p = 0.01) and more frequently as isolated distortion (20% vs 0%) (p = 0.03). ILC presented more often as asymmetries (60%) than masses (20%) on DM (p = 0.02) but not on DBT (35% vs 40%; p = 1.00). Conspicuity of ILC was significantly higher on DBT than on DM (p = 0.002), while the difference between the two techniques was not significant for IDC (p = 0.2). Regarding ILC, concordance in tumour size measurement between DBT and pathology was fair (intraclass correlation coefficient = 0.24).
ILC rarely presented as dense masses but frequently demonstrated architectural distortion on DBT. DBT increased lesion conspicuity but failed to accurately assess tumour size of ILC. Advances in knowledge: (1) This study describes specific features of ILC on DBT. (2) It shows that DBT can improve conspicuity of ILC.
回顾数字化乳腺断层合成(DBT)上浸润性小叶癌(ILC)与浸润性导管癌(IDC)相比的影像特征,并评估与数字化乳腺钼靶(DM)相比,DBT是否能提高ILC的可见性及肿瘤大小评估。
本回顾性研究获得机构审查委员会批准并豁免知情同意。纳入诊断时接受DBT和DM检查的ILC或IDC患者。两名乳腺放射科医生共同回顾DM和DBT图像,以评估ILC和IDC的影像特征、可见性及最大肿瘤直径。手术标本的病理检查被视为评估肿瘤大小的参考标准。
纳入43例患者(20例ILC患者和23例IDC患者)。在DBT上,与IDC相比,ILC表现为肿块的频率较低(40%对78%)(p = 0.01),表现为孤立性结构扭曲的频率较高(20%对0%)(p = 0.03)。在DM上,ILC表现为不对称的频率高于肿块(60%对20%)(p = 0.02),但在DBT上并非如此(35%对40%;p = 1.00)。ILC在DBT上的可见性显著高于DM(p = 0.002),而两种技术对IDC的差异不显著(p = 0.2)。对于ILC,DBT与病理检查在肿瘤大小测量上的一致性一般(组内相关系数 = 0.24)。
ILC在DBT上很少表现为致密肿块,但常显示结构扭曲。DBT提高了病变的可见性,但未能准确评估ILC的肿瘤大小。知识进展:(1)本研究描述了ILC在DBT上的特定特征。(2)表明DBT可提高ILC的可见性。